Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Contract Research & Services
Contract Services
Return to: PBR Home | Contract Research & Services | Contract Services | White Papers
Search Refinements

Contract Services White Papers

View white papers from other Pharmaceutical sectors:
31-45 of 68 results
Enhanced Sampling and Calibration Procedures for the Analysis of Residual Oxygen in Nitrogen Purged Pharmaceutical Packaging by GC-TCD
| By Butterworth Laboratories Ltd
In recent times there has been a large increase in the type and number of products packaged using Modified Atmosphere Packaging (MAP) procedures. The majority of these processes concern the removal of oxygen from packaging systems in order to reduce oxidative degradation of the product and increase shelf life. Whilst most of the historical development of MAP took place within the food industry, over the last 20 years there has been a large growth in its application within the pharmaceutical sector.
Contract Research & Services > Contract Services > White Papers
Transform Clinical Development Through Advances in Risk-Based Monitoring
| By Quintiles
This paper shares the challenges of clinical development along with an approach to trial execution gleaned from years of executing trials with risk-based monitoring (RBM) policies and processes.
Contract Research & Services > Contract Services > White Papers
Integration of Molecular Biomarkers into Clinical Development
| By Quintiles
In the first of this two-part series, strategic drug developers Eric Groves, Jason Hill and Christopher Ung explain why biopharma cannot afford to ignore the growing surge of interest in biomarkers in oncology and discuss their critical role in the modern-day clinical development process.
Contract Research & Services > Contract Services > White Papers
Personalizing Oncology with Genomics
| By Quintiles
Next-generation sequencing will transform oncology clinical trials and treatments for cancer.
Contract Research & Services > Contract Services > White Papers
Biomarkers: Recent Advances in Their Application to the Treatment of Hematologic Malignancies
| By Quintiles
Biomarkers hold promise in the diagnosis, prognosis and therapeutic stratification of hematopoietic malignancies. These heterogeneous diseases - including multiple myeloma, lymphomas and leukemias - are frequently characterized cytogenetically with diagnoses supported by genetic, immunohistochemical and flow cytometric analyses.
Contract Research & Services > Contract Services > White Papers
Integrating Biomarkers in Alzheimer’s Disease Trials
| By Quintiles
Review of compliance with biomarker assessments in Alzheimer’s disease clinical trials.
Contract Research & Services > Contract Services > White Papers
Biomarkers: Key to Better Rheumatoid Arthritis Drug Development and Treatment
| By Quintiles
Rheumatoid arthritis (RA) affects approximately 1% of the world’s population with an ever-increasing burden on health, quality of life and the economy.
Contract Research & Services > Contract Services > White Papers
Amino Acid Analysis in Pharmaceuticals
| By Butterworth Laboratories Ltd
The European Pharmacopeia (Ph Eur) is moving away from the historical Thin Layer Chromatography technique (TLC) for the determination of Ninhydrin-positive substances, to more specific and sensitive methods utilising Liquid Chromatography (LC) or Amino Acid Analysers. This paper will explore the history of the test, the benefits of the change and considerations for validation of the LC approach to analysis.
Contract Research & Services > Contract Services > White Papers
Enhanced Residual Solvents Analysis: A Practical Approach to Sampling, Transport, Storage and Analysis.
| By Butterworth Laboratories Ltd
Residual solvents are organic volatile chemicals used or produced in the manufacture of active pharmaceutical ingredients (API), excipients or drug products, which remain in the material at the end of the manufacturing process. Their control is important in limiting exposure and guidelines exist to maintain patient safety, not just to satisfy competent authorities. It is a requirement that all pharmaceutical substances comply with ICH limits even if not required by individual monographs or if no compendial monograph exists.
Contract Research & Services > Contract Services > White Papers
Elemental Impurity Analysis in Pharmaceuticals
| By Butterworth Laboratories Ltd
A method to identify the presence of heavy metals in pharmaceuticals was introduced in the United States Pharmacopoeia more than 100 years ago. Today pharmaceutical companies are still using essentially the same method, the USP <231> Heavy Metals Limit Test. This paper will give an overview of the current method limitations, considerations for the new methodology and the risk-based assessments being carried out by manufacturers.
Contract Research & Services > Contract Services > White Papers
Designing Wellness for Fun and Satisfaction: Gummies - Based Nutrition
| By Softigel pbr
The gummy delivery form for vitamins, minerals and supplements is the single-largest source of growth among the supplements category. Vitamin users report preference for gummy/soft chewable products because these offer not only pleasure and a fun experience, but efficacy and convenience. The selection of materials during the design process of the formula is critical for the final product in order to meet the expectations of the consumers, which is to find a healthy product that will give them a delicious reward as well. Based on the design and development process, this paper reviews review in detail the stage of selection of materials and validation as a critical phase to obtain a product that represents quality and stability as well as the specific requirements of the costumers and the consumers.
Contract Research & Services > Contract Services > White Papers
pAVEway™ Expression System for the Efficient Expression of Therapeutic Proteins
| By Fujifilm Diosynth Biotechnologies
One of the major bottlenecks in the production of biopharmaceuticals is the efficient expression of therapeutic proteins in microbial or mammalian cells. The Escherichia coli pAVEway™ expression system described here has been developed to ensure high product titres and efficient scale up to GMP manufacture, whilst minimising many common issues seen in other expression systems, such as ‘leaky’ expression (expression of recombinant protein in the absence of inducer).
Contract Research & Services > Contract Services > White Papers
Signed by Syncom - Designing Chemistry in 25 Milestones
| By Syncom BV pbr
There are so many reasons to be proud of this company. In the first 25 years of Syncoms’ existence, we have truly made a contribution to science, the pharmaceutical industry, the health of many people across all continents, to the economy of our city (Groningen), as well as to the careers and lives of employees and former employees.
Contract Research & Services > Contract Services > White Papers
Syncom Catalogue
| By Syncom BV pbr
Click here to download our catalogue of products.
Contract Research & Services > Contract Services > White Papers
31-45 of 68 results